Evaluating risk: benefit ratio of fat-soluble vitamin supplementation to sars-cov-2-infected autoimmune and cancer patients: do vitamin-drug interactions exist?

HIGHLIGHTS

• who: Radwa Y. Mekky et al. from the Department of Pharmacology and Toxicology, Faculty of Pharmacy, October University for Modern Sciences Antonius Deusinglaan, AV Groningen, The Netherlands have published the Article: Evaluating Risk: Benefit Ratio of Fat-Soluble Vitamin Supplementation to SARS-CoV-2-Infected Autoimmune and Cancer Patients: Do Vitamin-Drug Interactions Exist?, in the Journal: Life 2022, 1654 of /2022/
• what: Relevant publications with detailed information were included includingresearch articles, review articles and book chapters were evaluated and summarized to fulfill the purpose of this review article.
• future: Tumors Status of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.